Journal
PARKINSONISM & RELATED DISORDERS
Volume 15, Issue 6, Pages 414-416Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2008.08.004
Keywords
Gaucher; Parkinson; Genetic; Lewy body
Categories
Funding
- NPF Inc. [FL 33136]
Ask authors/readers for more resources
It has been proposed that there is an increased frequency of glucosidase-beta mutations in Lewy body disorders. Our comprehensive DNA sequencing approach found a small number of glucosidase-beta mutations in 101 neuropathologically defined Lewy body disease cases (3%) compared to 99 healthy postmortem controls (1%); odds ratio 3.0 (95% CI: 0.3-29, p = 0.3). All three affected carriers were classified as diffuse Lewy body disease (n = 3/50; 6%). Our study suggests glucosidase-beta variants have a limited role in susceptibility to Lewy body disease in North America. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available